We are live on ! Find out more
CASI

CASI Pharmaceuticals

Delisted

CASI was delisted on the 25th of February, 2026.

54 hedge funds and large institutions have $45.9M invested in CASI Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.04% less ownership

Funds ownership: 1.24%1.2% (-0.04%)

9% less capital invested

Capital invested by funds: $50.2M → $45.9M (-$4.3M)

14% less funds holding

Funds holding: 6354 (-9)

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

Holders
54
Holders Change
-9
Holders Change %
-14.29%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
22
Reduced
16
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RA
51
Royce & Associates
New York
-$368K -7,874 Closed
PA
52
Perceptive Advisors
New York
-$204K -4,368 Closed
Barclays
53
Barclays
United Kingdom
-$110K -2,360 Closed
D.E. Shaw & Co
54
D.E. Shaw & Co
New York
-$103K -2,198 Closed
MHP
55
Manatuck Hill Partners
Connecticut
-$70K -1,509 Closed
PAG
56
Private Advisor Group
New Jersey
-$70K -1,500 Closed
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
-$7.62K -163 Closed
SPIA
58
Steward Partners Investment Advisory
New York
-$1K -20 Closed
WSTAM
59
Wilbanks Smith & Thomas Asset Management
Virginia
-$1K -16 Closed
LF
60
Lee Financial
Texas
+$379 +10 New